ONCOLOGY DATA SYSTEMS, INC. – Trademark Portfolio

Entity Type: 03

ONCOLOGY DATA SYSTEMS, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 5 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include MU, MUCHECK, and BRACHYCHECK. The owner is based in Oklahoma City, OK.

1601 SW 89 Street, Building E-100

Oklahoma City, OK 73159

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MU
MU
Registered 2013
MUCHECK
MUCHECK
Registered 2007
MU
MU
Cancelled 1999
MUCHECK
MUCHECK
Cancelled 1999

Trademark Classifications

ONCOLOGY DATA SYSTEMS, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (5 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does ONCOLOGY DATA SYSTEMS, INC. have?

ONCOLOGY DATA SYSTEMS, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 cancelled.

What trademark classes does ONCOLOGY DATA SYSTEMS, INC. file in?

ONCOLOGY DATA SYSTEMS, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are ONCOLOGY DATA SYSTEMS, INC.'s most well-known trademarks?

ONCOLOGY DATA SYSTEMS, INC.'s registered trademark portfolio includes well-known marks such as MU, MUCHECK, and BRACHYCHECK. These are among 3 currently registered trademarks in the portfolio.

What is ONCOLOGY DATA SYSTEMS, INC.'s trademark registration success rate?

ONCOLOGY DATA SYSTEMS, INC. has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.